nurx semaglutide SEMA GLP-1 10mg My - Semaglutide for weight

Eli Lilly Press Release: Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial

Mestres, P

Yes Treatment Length: 30 Minutes Number of Sessions: 1 What it Treats: Type 2 diabetes, obesity Frequently Paired With Frequently Asked Questions Absolutely

Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% mean weight reduction at 48 weeks exceeding outcomes seen with dual GLP-1/GIP agonists

#ObesityMedicine #ADA2026 #GLP1 #WeightLossMedications #ObesityTreatment #Diabetes #CardiometabolicHealth To view or add a comment, sign in Psoriasis is a chronic immune-mediated disease associated with cardiovascular, metabolic, musculoskeletal, psychiatric, hepatic, kidney, and pulmonary comorbidities

However, this effect is usually short term and not considered a healthy method of losing weight